Pliant Therapeutics (PLRX) Research & Development (2019 - 2026)
Pliant Therapeutics (PLRX) posted Research & Development of $16.73 million for Q2 2026, down 48.0% from $32.2 million a year earlier but up 23.1% from the prior quarter.
Powered by 
Analysis
Pliant Therapeutics (PLRX) Research & Development (2019 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Pliant Therapeutics was $63.83 million, down 60.6% year-over-year; for FY2025, it was $109.16 million, down 35.5% from FY2024.
- Annual Research & Development shows a five-year compound annual growth rate of 10.5% (FY2020 to FY2025).
- In prior years, Pliant Therapeutics' Research & Development was $169.31 million in FY2024 (+32.5%), $127.8 million in FY2023 (+31.8%), $96.94 million in FY2022 (+25.0%) and $77.55 million in FY2021 (+17.2%).
- Quarterly Research & Development has run from a low of $13.58 million in Q1 2026 to a high of $47.75 million in Q3 2024 over five years.
- On a year-over-year basis, Research & Development has declined in each of the last five quarters, with an average decline of 23.4% over the last eight quarters.
- The strongest year-over-year quarter for Research & Development in the past five years was Q3 2024, with growth of 47.7%; the weakest was Q1 2026, with a decline of 68.7%.
- According to Business Quant data, Research & Development for the three prior quarters was $13.58 million (Q1 2026), $15.59 million (Q4 2025) and $17.94 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Pliant Therapeutics | 66.87 Mn | 66.87 Mn | - | 16.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.73 Mn |
| Mar 31, 2026 | 13.58 Mn |
| Dec 31, 2025 | 15.59 Mn |
| Sep 30, 2025 | 17.94 Mn |
| Jun 30, 2025 | 32.20 Mn |
| Mar 31, 2025 | 43.44 Mn |
| Dec 31, 2024 | 38.79 Mn |
| Sep 30, 2024 | 47.75 Mn |
| Jun 30, 2024 | 45.62 Mn |
| Mar 31, 2024 | 37.15 Mn |
| Dec 31, 2023 | 33.18 Mn |
| Sep 30, 2023 | 32.34 Mn |
| Jun 30, 2023 | 33.00 Mn |
| Mar 31, 2023 | 29.27 Mn |
| Dec 31, 2022 | 25.11 Mn |
| Sep 30, 2022 | 24.61 Mn |
| Jun 30, 2022 | 26.34 Mn |
| Mar 31, 2022 | 20.88 Mn |
| Dec 31, 2021 | 18.75 Mn |
| Sep 30, 2021 | 21.05 Mn |
API Access
Pliant Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=PLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "PLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=PLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();